Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dezocine Injection IV drip vs IV bolus for postoperative moderate pain
CTR20180959Phase 3Active
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Jul 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dezocine in postoperative pain, pain, sponsored by Yangtze River Pharmaceutical Group. Started Jul 2018; status: active.
02
Drugs
dezocine
03
Conditions
postoperative painpain
Beyond the preview
Go deeper on CTR20180959.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180959.